Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Cancer study sheds new light on premature menopause

Around two per cent of women with primary ovarian insufficiency €“ the medical term for a permanent halt in menstruation occurring naturally before the age of 40 €“ are affected by changes to a particular gene, a study has shown.

Around two per cent of women with primary ovarian insufficiency €“ the medical term for a permanent halt in menstruation occurring naturally before the age of 40 €“ are affected by changes to a particular gene, a study has shown. The study, led by Dr Anna Murray at the University of Exeter and including researchers from The Institute of Cancer Research, London, found that changes to the gene FMR1 are responsible for a smaller proportion of cases of primary ovarian insufficiency than some previous studies had suggested. This was the first study of women from the general population rather than

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy